Innovation Discoveries Series
November 30, 2018 – noon
Statin Use is Associated with Lower Osteoarthritis Occurrence in the Delaware Population
November 30, 2018 from 12:00-1:00 pm
In-person: Christiana Hospital, Ammon Back Auditorium
On-line: Watch live at https://bluejeans.com/361095905
Or join meeting ID 361095905 on the BlueJeans app on your smartphone or tablet
This activity has been approved for AMA PRA Category 1 Credit
| Statins are a class of drugs prescribed to over 40 million U.S. people to control the cholesterol levels. In this study, using the patient database at Christiana Health Care System, we investigated the impact of statin use on the symptomatic and radiological OA in the Delaware population. We found that the use of statin was associated with lower occurrence of osteoarthritis and other common musculoskeletal disorders, such as joint pain and low back pain. Further experiments at tissue and cell levels proved that statin can directly protect cartilage from osteoarthritis inducing factors. Statin can effectively prevent the initiation of osteoarthritis, but it may have little effect for the cessation or reversal of late OA progression. Our finding could increase the prescription adherence of current statin users, especially those at a high risk of OA development due to joint injury histories.
|
Meet the SpeakerDr. Lu is an Associate Professor at University of Delaware. His research interests are in osteoarthritis, prevention, treatment, and rehabilitation. Dr. Lu is also working on the early detection of circulatory tumor cells for cancer patients. His research is funded by DOD, NIH, NSF and private foundations. He has published over 50 articles in peer-reviewed journals and books. Dr. Lu is the recipient of 2016 Outstanding Junior Faculty Award of Engineering at the University of Delaware. |
 |